These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Radicicol Inhibits Chikungunya Virus Replication by Targeting Nonstructural Protein 2. Nam S; Ga YJ; Lee JY; Hwang WY; Jung E; Shin JS; Chen W; Choi G; Zhou B; Yeh JY; Go YY Antimicrob Agents Chemother; 2021 Jun; 65(7):e0013521. PubMed ID: 33903104 [TBL] [Abstract][Full Text] [Related]
6. Host Factor Nucleophosmin 1 (NPM1/B23) Exerts Antiviral Effects against Chikungunya Virus by Its Interaction with Viral Nonstructural Protein 3. Pradeep P; Sivakumar KC; Sreekumar E Microbiol Spectr; 2023 Aug; 11(4):e0537122. PubMed ID: 37409962 [TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H Virology; 2017 May; 505():102-112. PubMed ID: 28236746 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535 [TBL] [Abstract][Full Text] [Related]
9. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery. Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991 [TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus drug discovery: still a long way to go? Pérez-Pérez MJ; Delang L; Ng LFP; Priego EM Expert Opin Drug Discov; 2019 Sep; 14(9):855-866. PubMed ID: 31177861 [No Abstract] [Full Text] [Related]
11. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review. Lo Presti A; Cella E; Angeletti S; Ciccozzi M Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491 [TBL] [Abstract][Full Text] [Related]
13. Current Strategies for Inhibition of Chikungunya Infection. Subudhi BB; Chattopadhyay S; Mishra P; Kumar A Viruses; 2018 May; 10(5):. PubMed ID: 29751486 [TBL] [Abstract][Full Text] [Related]
15. Current and Promising Antivirals Against Chikungunya Virus. Hucke FIL; Bugert JJ Front Public Health; 2020; 8():618624. PubMed ID: 33384981 [TBL] [Abstract][Full Text] [Related]
18. Development of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cells. Gong EY; Bonfanti JF; Ivens T; Van der Auwera M; Van Kerckhove B; Kraus G Methods Mol Biol; 2013; 1030():429-38. PubMed ID: 23821286 [TBL] [Abstract][Full Text] [Related]
19. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents. Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048 [TBL] [Abstract][Full Text] [Related]
20. Drug repurposing approach against chikungunya virus: an Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]